Clinical Trial Update: Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial [Phase 3]

View source ↗

Summary

This clinical trial update provides long-term clinical and immunological follow-up data from pemphigus patients in the Phase 3 RITUXIMAB 3 trial. The update hig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Autoimmune Diseases | Phase 3 | Status: COMPLETED